Chris Rose of ProStrakan offers advice on selling in the pharmaceutical industry. The 80's and 90's spawned a host of selling models and most of us in the pharma business have been trained to use ...

What is Pharma 4.0? The term Industry 4.0 refers to the fourth industrial revolution, associated with the application of advanced technologies that have dramatically changed the landscape of ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

The previous Paralympic logo incorporated the Tae-Geuk, which is a traditional Korean decorative motif. According to oriental philosophy, Tae-Geuk refers to the ultimate reality from which all things ...

Students acquire in- depth knowledge in various fields of Pharmaceutical Sciences and gain scientific skills and insight into drug development prozess. Compulsory subjects, electives and a research ...

Hormones. These are a few of the cutting-edge therapies and medicines being manufactured in Bangladesh, helping build the country’s reputation as a global pharmaceutical hub. Bangladesh’s ...

Medicinal chemists are known to explore new areas and work to improve human health and reduce suffering. A good imagination and persistence are required. Medicinal and pharmaceutical chemists apply ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The global pharmaceutical industry is growing and offers an attractive opportunity for investors. Well-established pharmaceutical stocks include AbbVie, Eli Lilly, Johnson & Johnson, and Pfizer.

Currently, the size of the global pharmaceutical market is around 1.6 trillion U.S. dollars. The range of pharma products varies from antibiotics which haven’t changed much in almost a century ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...